|
|
Vaccine Detail
|
Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [ACEL-IMUNE] |
| Vaccine Information |
- Vaccine Name: Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [ACEL-IMUNE]
- Target Pathogen: Clostridium tetani
- Target Disease: Tetanus
- Tradename: ACEL-IMUNE
- Vaccine Ontology ID: VO_0019421
- Type: inactivated vaccine|toxoid vaccine
- Status: FDA licensed vaccine
- Host Species for Licensed Use: Human
|
| Host Response |
|
|
| References |
|
|
|
